SF3B1 and B-cell chronic lymphocytic leukemia: In the subgroup analysis of PFS, only one study was divided into Asia group (HR 1.87, 95%CI 0.92-3.80), which suggested that there was no statistically significant associations between SF3B1 mutation and PFS of CLL patients.